Related references
Note: Only part of the references are listed.Assessing the impact of PCSK9 inhibition on coronary plaque phenotype with optical coherence tomography: rationale and design of the randomized, placebo-controlled HUYGENS study
Stephen J. Nicholls et al.
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Effect of evolocumab therapy on coronary fibrous cap thickness assessed by optical coherence tomography in patients with acute coronary syndrome
Hideki Yano et al.
JOURNAL OF CARDIOLOGY (2020)
Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: A 12-month follow-up
Cristina Barale et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
Efficacy and tolerability of alirocumab in Austrian clinical practice - results of the non-interventional PEARL-AT study
Deborah R. Leitner et al.
CURRENT MEDICAL RESEARCH AND OPINION (2020)
Effects of Evolocumab on Carotid Intima-Media Thickness and Clinical Parameters in Patients Taking a Statin
Keiji Hirai et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk: From the American Society of Echocardiography
Amer M. Johri et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2020)
Adding Alirocumab to Rosuvastatin Helps Reduce the Vulnerability of Thin-Cap Fibroatheroma
Yoichiro Sugizaki et al.
JACC-CARDIOVASCULAR IMAGING (2020)
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy
Alessandro Di Minno et al.
THROMBOSIS RESEARCH (2020)
Evolocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, promotes angiogenesis in vitro
Leila Safaeian et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2019)
Alirocumab in Acute Myocardial Infarction: Results From the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT)
Cory R. Trankle et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
PCSK9 and inflammation: a review of experimental and clinical evidence
Amir Abbas Momtazi-Borojeni et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2019)
Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome - The ODYSSEY J-IVUS Trial
Junya Ako et al.
CIRCULATION JOURNAL (2019)
PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers
Renate M. Hoogeveen et al.
JACC-CARDIOVASCULAR IMAGING (2019)
Magnetic resonance microscopy diffusion tensor imaging of collagen fibre bundles stabilizing an atherosclerotic plaque of the common carotid artery
Peter Opriessnig et al.
EUROPEAN HEART JOURNAL (2018)
Improved endothelial function after short-term therapy with evolocumab
Guglielmo Maulucci et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Effect of Evolocumab on Coronary Plaque Composition
Stephen J. Nicholls et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled Trials
Michiel L. Bots et al.
CHINESE MEDICAL JOURNAL (2016)
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients The GLAGOV Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
In vivo cardiovascular magnetic resonance of 2D vessel wall diffusion anisotropy in carotid arteries
Peter Opriessnig et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2016)
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society
Charalambos Vlachopoulos et al.
ATHEROSCLEROSIS (2015)
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention The Multicenter Randomized Controlled PRECISE-IVUS Trial
Kenichi Tsujita et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Normal values for intima-media thickness of the common carotid artery - an update following a novel risk factor profiling
Elko Randrianarisoa et al.
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE (2015)
Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study
Lorenz Raeber et al.
EUROPEAN HEART JOURNAL (2015)
Endothelial Dysfunction and Brachial Intima-Media Thickness: Long Term Cardiovascular Risk with Claudication Related to Peripheral Arterial Disease: A Prospective Analysis
Franz Hafner et al.
PLOS ONE (2014)
Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: The Atherosclerosis Risk in Communities (ARIC) carotid MRI study
Salim S. Virani et al.
ATHEROSCLEROSIS (2011)
Pitavastatin, an HMG-CoA Reductase Inhibitor, Ameliorates Endothelial Function in Chronic Smokers
Osamu Yoshida et al.
CIRCULATION JOURNAL (2010)
Are flow-mediated vasodilatation and intima-media thickness of the brachial artery associated with restenosis after endovascular treatment of peripheral arterial occlusive disease?
F. Hafner et al.
EUROPEAN RADIOLOGY (2010)
Short-Term Effect of Atorvastatin on Endothelial Function in Healthy Offspring of Parents with Type 2 Diabetes Mellitus
Kadirvelu Amudha et al.
CARDIOVASCULAR THERAPEUTICS (2008)
Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina
E Karatzis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Simvastatin versus ezetimibe -: Pleiotropic and lipid-lowering effects on endothelial function in humans
U Landmesser et al.
CIRCULATION (2005)
Variability of flow mediated dilation: consequences for clinical application
ML Hijmering et al.
ATHEROSCLEROSIS (2001)
Share Paper
